About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hematology and Oncology
›
top-articles
Department of Hematology and Oncology
45
(top 2%)
papers
660
(top 2%)
citations
13
(top 2%)
h
-index
26
(top 2%)
g
-index
49
all documents
746
doc citations
353
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)
Annals of Hematology
2019
108
2
The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey
Annals of Hematology
2017
92
3
Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
Annals of Hematology
2014
86
4
Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors
Blood
2018
54
5
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Annals of Hematology
2021
54
6
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
Leukemia
2022
42
7
Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activities
Cell Communication and Signaling
2013
40
8
Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells
Nature Communications
2017
35
9
Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo
Leukemia
2016
33
10
Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo
Leukemia
2020
27
11
Mitochondrial BAX Determines the Predisposition to Apoptosis in Human AML
Clinical Cancer Research
2017
26
12
Baseline Chest Computed Tomography as Standard of Care in High-Risk Hematology Patients
Journal of Fungi (Basel, Switzerland)
2020
15
13
Leukemogenic potency of the novel FLT3-N676K mutant
Annals of Hematology
2016
14
14
Fibrosis and Immune Cell Infiltration Are Separate Events Regulated by Cell-Specific Receptor Notch3 Expression
Journal of the American Society of Nephrology: JASN
2020
14
15
Gain of function in Jak2V617F-positive T-cells
Leukemia
2017
11
16
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
Annals of Hematology
2021
11
17
Central venous catheter–related bloodstream infections in patients with hematological malignancies: Comparison of data from a clinical registry and a randomized controlled trial
Infection Control and Hospital Epidemiology
2020
9
18
Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma
Molecular and Clinical Oncology
2014
8
19
CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints
Cells
2022
8
20
Impact of neutropenia on central venous catheter–related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: A matched-pair analysis
Infection Control and Hospital Epidemiology
2019
7
21
A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients
Leukemia
2023
6
22
Central Venous Catheter–Related Bloodstream Infections in Obese Hematologic Patients
Infection Control and Hospital Epidemiology
2015
5
23
Diagnostic and therapeutic challenges in extragonadal yolk sac tumor with hepatoid differentiation: A case report
Molecular and Clinical Oncology
2017
5
24
Determination of a Cutoff Time Point for Prophylactic Exchange of Central Venous Catheters for Prevention of Central Venous Catheter–Related Bloodstream Infections in Patients with Hematological Malignancies
Infection Control and Hospital Epidemiology
2017
5
25
Outcomes of
anti‐programmed death 1
treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group
multicentre real‐world
analysis
British Journal of Haematology
2022
5
26
Long-Term Remission in a Patient with Carcinoma of Unknown Primary Site
Chemotherapy
2006
4
27
SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA
Haematologica
2019
4
28
Influence of different definitions of central venous catheter–related bloodstream infections on epidemiological parameters in cancer patients
Infection Control and Hospital Epidemiology
2021
4
29
Biased Low Incidence of Central Venous Catheter-Related Bloodstream Infections in Controlled Clinical Trials?
Infection Control and Hospital Epidemiology
2016
3
30
Optimized and Personalized Phlebotomy Schedules for Patients Suffering From Polycythemia Vera
Frontiers in Physiology
2020
3
31
Prognostic Impact of Quality and Distribution of Adipose Tissue in Patients With Primary Central Nervous System Lymphoma
In Vivo
2022
2
32
Hemophagocytic lymphohistiocytosis as an unusual cause of prolonged bicytopenia after chemotherapy
Clinical Case Reports (discontinued)
2016
1
33
HIV/AIDS-Related Refractory Kaposi Sarcoma Causing Severe Leg Lymphedema
Open Forum Infectious Diseases
2019
1
34
Internal Tandem Duplication (ITD) in the Tyrosine Kinase Domain of FLT3 Displays Higher Oncogenic Potential in Acute Myeloid Leukemia
Blood
2016
1
35
Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma: A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis
Blood
2021
1
36
Overweight or obesity are not risk factors for central venous catheter–related bloodstream infections in patients with hematological malignancies
Infection Control and Hospital Epidemiology
2021
1
37
Treatment intensification might not improve survival in high‐grade B‐cell lymphoma with a concurrent
MYC
and
BCL2
and/or
BCL6
rearrangement: A retrospective, multicenter, pooled analysis
Hematological Oncology
2023
1
38
Multidrug-Resistant Gram-Negative Bacteria in Hematology and Oncology
Infection Control and Hospital Epidemiology
2014
0
39
Leukemic mastopathy
International Journal of Hematology
2016
0
40
Dose reduction and high-risk disease as risk factors for early death in primary CNS lymphoma
Leukemia and Lymphoma
2020
0
41
The Novel FLT3-N676K Mutant Induces Acute Leukemia Independently of the Inv(16) Chimeric Gene CBFB-MYH11
Blood
2015
0
42
The Impact of Myeloproliferative Neoplasms (MPNs) on Patients' Quality of Life and Productivity: Results from the International MPN Landmark Survey
Blood
2016
0
43
PS1443 BLOCKADE OF TNFR1 RATHER THAN TNFR2 IMPROVES HEMATOCRIT AND REDUCES BLOOD PRO-INFLAMMATORY CYTOKINE LEVELS IN THE VAV1-CRE X JAK2+/V617F MPN MOUSE MODEL
HemaSphere
2019
0
44
Jugular vein inserted central venous catheters (
CVC
) and the risk of
CVC
‐related bloodstream infections in patients with hematological malignancies
American Journal of Hematology
2022
0
45
Lipotoxicity as a Barrier for T Cell-Based Therapies
Biomolecules
2022
0
46
Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry
Infection
0
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.